Bayer AG Correlations

BAYZF Stock  USD 33.50  1.24  3.84%   
The current 90-days correlation between Bayer AG and Monster Beverage Corp is -0.08 (i.e., Good diversification). The correlation of Bayer AG is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
  
The ability to find closely correlated positions to Bayer AG could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bayer AG when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bayer AG - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bayer AG to buy it.

Moving together with Bayer OTC Stock

  0.81NVS Novartis AG ADRPairCorr
  0.81NVSEF Novartis AGPairCorr
  0.7VICI VICI Properties Earnings Call This WeekPairCorr
  0.87VIV Telefonica Brasil Earnings Call This WeekPairCorr
  0.72ASMVF ASM Pacific TechnologyPairCorr
  0.63BCAL Southern California Earnings Call This WeekPairCorr
  0.71LC LendingClub Corp Earnings Call This WeekPairCorr
  0.91BNS Bank of Nova ScotiaPairCorr
  0.9DLTR Dollar TreePairCorr

Moving against Bayer OTC Stock

  0.47EEIQ Elite Education GroupPairCorr
  0.7CHNXF ChitogenXPairCorr
  0.45AILIH Ameren IllinoisPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
PMNXFAUST
OTLYIIIN
TTAMIIIN
MNSTPMNXF
OTLYPMNXF
OTLYAUST
  
High negative correlations   
MNSTSNDL
SNDLAUST
SNDLPMNXF
SNDLIIIN
MNSTGRMC
TTAMGRMC

Risk-Adjusted Indicators

There is a big difference between Bayer OTC Stock performing well and Bayer AG OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bayer AG's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Bayer AG without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fundamentals Comparison Now

   

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
All  Next Launch Module

Bayer AG Corporate Management

Elected by the shareholders, the Bayer AG's board of directors comprises two types of representatives: Bayer AG inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bayer. The board's role is to monitor Bayer AG's management team and ensure that shareholders' interests are well served. Bayer AG's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bayer AG's outside directors are responsible for providing unbiased perspectives on the board's policies.
Sarena LinLabor OfficerProfile
Oliver MaierHead RelationsProfile
Gabriel HarnierPatents LawProfile
Heiko SchipperMember of the Management Board, Head of the Consumer Health DivisionProfile
Rodrigo SantosMember DivisionProfile
Michael PreussGov CommunicationsProfile
Stefan OelrichMember of the Management Board, Head of the Pharmaceuticals DivisionProfile